These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32098853)

  • 21. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
    Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW
    Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Iqbal S; Li R; Gargiullo P; Vellozzi C
    Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
    Greene SK; Rett M; Weintraub ES; Li L; Yin R; Amato AA; Ho DT; Sheikh SI; Fireman BH; Daley MF; Belongia EA; Jacobsen SJ; Baxter R; Lieu TA; Kulldorff M; Vellozzi C; Lee GM
    Am J Epidemiol; 2012 Jun; 175(11):1100-9. PubMed ID: 22582210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
    Le Vu S; Bertrand M; Botton J; Jabagi MJ; Drouin J; Semenzato L; Weill A; Dray-Spira R; Zureik M
    Neurology; 2023 Nov; 101(21):e2094-e2102. PubMed ID: 37788935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study.
    Levison LS; Thomsen RW; Andersen H
    Eur J Neurol; 2022 Nov; 29(11):3389-3394. PubMed ID: 35913431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines and the risk of Guillain-Barré syndrome.
    Chen Y; Zhang J; Chu X; Xu Y; Ma F
    Eur J Epidemiol; 2020 Apr; 35(4):363-370. PubMed ID: 31858323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
    Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome.
    Hawken S; Kwong JC; Deeks SL; Crowcroft NS; McGeer AJ; Ducharme R; Campitelli MA; Coyle D; Wilson K
    Emerg Infect Dis; 2015 Feb; 21(2):224-31. PubMed ID: 25625590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019.
    Fujimori M; Hasegawa S; Sasaoka S; Iguchi K; Nakamura M
    Pharmazie; 2021 Sep; 76(9):437-443. PubMed ID: 34481535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccination and Guillain Barre syndrome.
    Geier MR; Geier DA; Zahalsky AC
    Clin Immunol; 2003 May; 107(2):116-21. PubMed ID: 12763480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
    Vellozzi C; Iqbal S; Stewart B; Tokars J; DeStefano F
    Am J Public Health; 2014 Apr; 104(4):696-701. PubMed ID: 24524517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older.
    Shi XC; Gruber JF; Ondari M; Lloyd PC; Freyria Duenas P; Clarke TC; Nadimpalli G; Cho S; Feinberg L; Hu M; Chillarige Y; Kelman JA; Forshee RA; Anderson SA; Shoaibi A
    Vaccine; 2024 May; 42(15):3486-3492. PubMed ID: 38704258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.
    Burwen DR; Sandhu SK; MaCurdy TE; Kelman JA; Gibbs JM; Garcia B; Markatou M; Forshee RA; Izurieta HS; Ball R;
    Am J Public Health; 2012 Oct; 102(10):1921-7. PubMed ID: 22970693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.